EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieKlinische Studie (Phase III)Open Access

Chinese herbal medicine (JianPi-BuShen) and completion rate of adjuvant chemotherapy for patients with stage II and III colon cancer: A randomized clinical trial

Lingyun Sun, Yun Xu, Nan Chen, Chunze Zhang, Aiwen Wu, Huaqing Wang, Yutong Fei, Peng Shu, Dechang Diao, Jianping Cheng, Yuping Chu, Tianshu Liu und 20 weitere

European Journal of Cancer · 2024-12 · 213 · 115109

DOI: 10.1016/j.ejca.2024.115109 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Cancer, 2024-12. Verfasst von Lingyun Sun und 31 weiteren Autor:innen. Beteiligte Einrichtung: Xiyuan Hospital, China Academy of Chinese Medical Sciences, China. Electronic address: slyslysun@126.com. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Colonic Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Neoplasm Staging. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalColonic NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsNeoplasm StagingCapecitabineHumansMaleFemaleMiddle AgedChemotherapy, AdjuvantAgedOxaliplatinQuality of LifeAdult

Stichwörter der Autor:innen

Adjuvant chemotherapyColon cancerCompletion rateRandomized controlled trialRelative dose intensityTraditional Chinese herbal medicine

Substanzen

Drugs, Chinese HerbalCapecitabineOxaliplatin

Autor:innen und Institutionen

  • Xiyuan Hospital, China Academy of Chinese Medical Sciences, China. Electronic address: slyslysun@126.com.
  • Xiyuan Hospital, China Academy of Chinese Medical Sciences, China.
  • Beijing Cancer Hospital, China.
  • Tianjin People's Hospital, China.
  • Beijing University of Chinese Medicine, China.
  • Jaingsu Provincial TCM Hospital, China.

Förderung

  • NCI NIH HHS

Zitieren

APA

Sun, L., Xu, Y., Chen, N., Zhang, C., Wu, A., Wang, H., Fei, Y., Shu, P., Diao, D., Cheng, J., Chu, Y., Liu, T., Wang, W., Yuan, Y., Zeng, B., Cao, Y., Cang, S., Cao, H., Zhang, T., …, & Yang, Y. (2024). Chinese herbal medicine (JianPi-BuShen) and completion rate of adjuvant chemotherapy for patients with stage II and III colon cancer: A randomized clinical trial. European Journal of Cancer, 213, 115109. https://doi.org/10.1016/j.ejca.2024.115109

Vancouver

Sun L, Xu Y, Chen N, Zhang C, Wu A, Wang H, et al. Chinese herbal medicine (JianPi-BuShen) and completion rate of adjuvant chemotherapy for patients with stage II and III colon cancer: A randomized clinical trial. European Journal of Cancer. 2024;213:115109. doi:10.1016/j.ejca.2024.115109

BibTeX
@article{Sun2024,
  author = {Sun, Lingyun and Xu, Yun and Chen, Nan and Zhang, Chunze and Wu, Aiwen and Wang, Huaqing and Fei, Yutong and Shu, Peng and Diao, Dechang and Cheng, Jianping and Chu, Yuping and Liu, Tianshu and Wang, Wei and Yuan, Ye and Zeng, Baozhu and Cao, Yang and Cang, Shundong and Cao, Huijuan and Zhang, Tong and Zheng, Yang and Wu, Cun'en and Liu, Shaoyong and He, Bin and Yan, Yunzi and Yan, Shaohua and Wu, Na and Ning, Chunhui and Peng, Rongyan and Epstein, Andrew S and Cytryn, Samuel and Mao, Jun J and Yang, Yufei},
  title = {Chinese herbal medicine (JianPi-BuShen) and completion rate of adjuvant chemotherapy for patients with stage II and III colon cancer: A randomized clinical trial},
  journal = {European Journal of Cancer},
  year = {2024},
  volume = {213},
  pages = {115109},
  doi = {10.1016/j.ejca.2024.115109}
}
Kostenlos starten →